Liposomal Amphoteracin B Market - Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: L2B4B9372365EN
Market Monitor Global

Abstracts

Ambisome (amphotericin B) is used to treat serious, life-threatening fungal infections, including a certain form of meningitis.

This report contains market size and forecasts of Liposomal Amphoteracin B in global, including the following market information:

Global Liposomal Amphoteracin B Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Liposomal Amphoteracin B Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Liposomal Amphoteracin B companies in 2021 (%)

The global Liposomal Amphoteracin B market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

25mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liposomal Amphoteracin B include Gilead Sciences and Cipla etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomal Amphoteracin B manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liposomal Amphoteracin B Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Amphoteracin B Market Segment Percentages, by Type, 2021 (%)

• 25mg
• 50mg

Global Liposomal Amphoteracin B Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Amphoteracin B Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy

Global Liposomal Amphoteracin B Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Liposomal Amphoteracin B Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liposomal Amphoteracin B revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Liposomal Amphoteracin B revenues share in global market, 2021 (%)

Key companies Liposomal Amphoteracin B sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Liposomal Amphoteracin B sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• Cipla

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liposomal Amphoteracin B Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liposomal Amphoteracin B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPOSOMAL AMPHOTERACIN B OVERALL MARKET SIZE

2.1 Global Liposomal Amphoteracin B Market Size: 2021 VS 2028
2.2 Global Liposomal Amphoteracin B Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Liposomal Amphoteracin B Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Liposomal Amphoteracin B Players in Global Market
3.2 Top Global Liposomal Amphoteracin B Companies Ranked by Revenue
3.3 Global Liposomal Amphoteracin B Revenue by Companies
3.4 Global Liposomal Amphoteracin B Sales by Companies
3.5 Global Liposomal Amphoteracin B Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Liposomal Amphoteracin B Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Liposomal Amphoteracin B Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomal Amphoteracin B Players in Global Market
  3.8.1 List of Global Tier 1 Liposomal Amphoteracin B Companies
  3.8.2 List of Global Tier 2 and Tier 3 Liposomal Amphoteracin B Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Liposomal Amphoteracin B Market Size Markets, 2021 & 2028
  4.1.2 25mg
  4.1.3 50mg
4.2 By Type - Global Liposomal Amphoteracin B Revenue & Forecasts
  4.2.1 By Type - Global Liposomal Amphoteracin B Revenue, 2017-2022
  4.2.2 By Type - Global Liposomal Amphoteracin B Revenue, 2023-2028
  4.2.3 By Type - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
4.3 By Type - Global Liposomal Amphoteracin B Sales & Forecasts
  4.3.1 By Type - Global Liposomal Amphoteracin B Sales, 2017-2022
  4.3.2 By Type - Global Liposomal Amphoteracin B Sales, 2023-2028
  4.3.3 By Type - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
4.4 By Type - Global Liposomal Amphoteracin B Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liposomal Amphoteracin B Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
5.2 By Application - Global Liposomal Amphoteracin B Revenue & Forecasts
  5.2.1 By Application - Global Liposomal Amphoteracin B Revenue, 2017-2022
  5.2.2 By Application - Global Liposomal Amphoteracin B Revenue, 2023-2028
  5.2.3 By Application - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
5.3 By Application - Global Liposomal Amphoteracin B Sales & Forecasts
  5.3.1 By Application - Global Liposomal Amphoteracin B Sales, 2017-2022
  5.3.2 By Application - Global Liposomal Amphoteracin B Sales, 2023-2028
  5.3.3 By Application - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
5.4 By Application - Global Liposomal Amphoteracin B Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liposomal Amphoteracin B Market Size, 2021 & 2028
6.2 By Region - Global Liposomal Amphoteracin B Revenue & Forecasts
  6.2.1 By Region - Global Liposomal Amphoteracin B Revenue, 2017-2022
  6.2.2 By Region - Global Liposomal Amphoteracin B Revenue, 2023-2028
  6.2.3 By Region - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
6.3 By Region - Global Liposomal Amphoteracin B Sales & Forecasts
  6.3.1 By Region - Global Liposomal Amphoteracin B Sales, 2017-2022
  6.3.2 By Region - Global Liposomal Amphoteracin B Sales, 2023-2028
  6.3.3 By Region - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Liposomal Amphoteracin B Revenue, 2017-2028
  6.4.2 By Country - North America Liposomal Amphoteracin B Sales, 2017-2028
  6.4.3 US Liposomal Amphoteracin B Market Size, 2017-2028
  6.4.4 Canada Liposomal Amphoteracin B Market Size, 2017-2028
  6.4.5 Mexico Liposomal Amphoteracin B Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Liposomal Amphoteracin B Revenue, 2017-2028
  6.5.2 By Country - Europe Liposomal Amphoteracin B Sales, 2017-2028
  6.5.3 Germany Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.4 France Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.5 U.K. Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.6 Italy Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.7 Russia Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.8 Nordic Countries Liposomal Amphoteracin B Market Size, 2017-2028
  6.5.9 Benelux Liposomal Amphoteracin B Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Liposomal Amphoteracin B Revenue, 2017-2028
  6.6.2 By Region - Asia Liposomal Amphoteracin B Sales, 2017-2028
  6.6.3 China Liposomal Amphoteracin B Market Size, 2017-2028
  6.6.4 Japan Liposomal Amphoteracin B Market Size, 2017-2028
  6.6.5 South Korea Liposomal Amphoteracin B Market Size, 2017-2028
  6.6.6 Southeast Asia Liposomal Amphoteracin B Market Size, 2017-2028
  6.6.7 India Liposomal Amphoteracin B Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Liposomal Amphoteracin B Revenue, 2017-2028
  6.7.2 By Country - South America Liposomal Amphoteracin B Sales, 2017-2028
  6.7.3 Brazil Liposomal Amphoteracin B Market Size, 2017-2028
  6.7.4 Argentina Liposomal Amphoteracin B Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Liposomal Amphoteracin B Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Liposomal Amphoteracin B Sales, 2017-2028
  6.8.3 Turkey Liposomal Amphoteracin B Market Size, 2017-2028
  6.8.4 Israel Liposomal Amphoteracin B Market Size, 2017-2028
  6.8.5 Saudi Arabia Liposomal Amphoteracin B Market Size, 2017-2028
  6.8.6 UAE Liposomal Amphoteracin B Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Liposomal Amphoteracin B Major Product Offerings
  7.1.4 Gilead Sciences Liposomal Amphoteracin B Sales and Revenue in Global (2017-2022)
  7.1.5 Gilead Sciences Key News
7.2 Cipla
  7.2.1 Cipla Corporate Summary
  7.2.2 Cipla Business Overview
  7.2.3 Cipla Liposomal Amphoteracin B Major Product Offerings
  7.2.4 Cipla Liposomal Amphoteracin B Sales and Revenue in Global (2017-2022)
  7.2.5 Cipla Key News

8 GLOBAL LIPOSOMAL AMPHOTERACIN B PRODUCTION CAPACITY, ANALYSIS

8.1 Global Liposomal Amphoteracin B Production Capacity, 2017-2028
8.2 Liposomal Amphoteracin B Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomal Amphoteracin B Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LIPOSOMAL AMPHOTERACIN B SUPPLY CHAIN ANALYSIS

10.1 Liposomal Amphoteracin B Industry Value Chain
10.2 Liposomal Amphoteracin B Upstream Market
10.3 Liposomal Amphoteracin B Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Liposomal Amphoteracin B Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Liposomal Amphoteracin B in Global Market
Table 2. Top Liposomal Amphoteracin B Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Liposomal Amphoteracin B Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Liposomal Amphoteracin B Revenue Share by Companies, 2017-2022
Table 5. Global Liposomal Amphoteracin B Sales by Companies, (K Units), 2017-2022
Table 6. Global Liposomal Amphoteracin B Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Liposomal Amphoteracin B Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Liposomal Amphoteracin B Product Type
Table 9. List of Global Tier 1 Liposomal Amphoteracin B Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Amphoteracin B Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposomal Amphoteracin B Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Liposomal Amphoteracin B Sales (K Units), 2017-2022
Table 15. By Type - Global Liposomal Amphoteracin B Sales (K Units), 2023-2028
Table 16. By Application – Global Liposomal Amphoteracin B Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Liposomal Amphoteracin B Sales (K Units), 2017-2022
Table 20. By Application - Global Liposomal Amphoteracin B Sales (K Units), 2023-2028
Table 21. By Region – Global Liposomal Amphoteracin B Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Liposomal Amphoteracin B Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Liposomal Amphoteracin B Sales (K Units), 2017-2022
Table 25. By Region - Global Liposomal Amphoteracin B Sales (K Units), 2023-2028
Table 26. By Country - North America Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Liposomal Amphoteracin B Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Liposomal Amphoteracin B Sales, (K Units), 2017-2022
Table 29. By Country - North America Liposomal Amphoteracin B Sales, (K Units), 2023-2028
Table 30. By Country - Europe Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Liposomal Amphoteracin B Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Liposomal Amphoteracin B Sales, (K Units), 2017-2022
Table 33. By Country - Europe Liposomal Amphoteracin B Sales, (K Units), 2023-2028
Table 34. By Region - Asia Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Liposomal Amphoteracin B Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Liposomal Amphoteracin B Sales, (K Units), 2017-2022
Table 37. By Region - Asia Liposomal Amphoteracin B Sales, (K Units), 2023-2028
Table 38. By Country - South America Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Liposomal Amphoteracin B Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Liposomal Amphoteracin B Sales, (K Units), 2017-2022
Table 41. By Country - South America Liposomal Amphoteracin B Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Liposomal Amphoteracin B Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Liposomal Amphoteracin B Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Liposomal Amphoteracin B Sales, (K Units), 2023-2028
Table 46. Gilead Sciences Corporate Summary
Table 47. Gilead Sciences Liposomal Amphoteracin B Product Offerings
Table 48. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Cipla Corporate Summary
Table 50. Cipla Liposomal Amphoteracin B Product Offerings
Table 51. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Liposomal Amphoteracin B Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 53. Global Liposomal Amphoteracin B Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Liposomal Amphoteracin B Production by Region, 2017-2022 (K Units)
Table 55. Global Liposomal Amphoteracin B Production by Region, 2023-2028 (K Units)
Table 56. Liposomal Amphoteracin B Market Opportunities & Trends in Global Market
Table 57. Liposomal Amphoteracin B Market Drivers in Global Market
Table 58. Liposomal Amphoteracin B Market Restraints in Global Market
Table 59. Liposomal Amphoteracin B Raw Materials
Table 60. Liposomal Amphoteracin B Raw Materials Suppliers in Global Market
Table 61. Typical Liposomal Amphoteracin B Downstream
Table 62. Liposomal Amphoteracin B Downstream Clients in Global Market
Table 63. Liposomal Amphoteracin B Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Liposomal Amphoteracin B Segment by Type
Figure 2. Liposomal Amphoteracin B Segment by Application
Figure 3. Global Liposomal Amphoteracin B Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liposomal Amphoteracin B Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomal Amphoteracin B Revenue, 2017-2028 (US$, Mn)
Figure 7. Liposomal Amphoteracin B Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Liposomal Amphoteracin B Revenue in 2021
Figure 9. By Type - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 10. By Type - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 11. By Type - Global Liposomal Amphoteracin B Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 13. By Application - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 14. By Application - Global Liposomal Amphoteracin B Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 16. By Region - Global Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 17. By Country - North America Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 18. By Country - North America Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 19. US Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 24. Germany Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 25. France Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 33. China Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 37. India Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 39. By Country - South America Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 40. Brazil Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Liposomal Amphoteracin B Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Liposomal Amphoteracin B Sales Market Share, 2017-2028
Figure 44. Turkey Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Liposomal Amphoteracin B Revenue, (US$, Mn), 2017-2028
Figure 48. Global Liposomal Amphoteracin B Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Liposomal Amphoteracin B by Region, 2021 VS 2028
Figure 50. Liposomal Amphoteracin B Industry Value Chain
Figure 51. Marketing Channels